TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: 5D Pruritus Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: pain subscale scores from WOMAC
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: physical function subscale scores from WOMAC
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: patient global assessment (PGA) of osteoarthritis
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients with depression and/or self-harm episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment initiated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients referred
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Small Intestinal Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in recovery time after a workout
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of complete achievement of steps 1 and 2
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Occurrence of local skin reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of other adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of health disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sociological consequences
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Change in percent total body weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Concentration of Neutrophil
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentration of eosinophil
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentration of basophil
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentration of monocyte
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentration of lymphocyte
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Concentration of CD4+
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Completion rates of outcome measures
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: day-28 mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Adherent area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 90-day favorable outcome
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in percentage of accurately produced words
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality and Independence of Gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: # of Enrolled Participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: % of Enrolled Participants From NIH-defined Racial or Ethnic Disparity Groups
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Severe or Serious Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Behavioral index of moral decision task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time percentage in the range of 3.9~10.0 mmol/L blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Spinal anesthesia-induced hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Compensatory response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who experienced dose-limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants who experienced an adverse event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in effort valuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in reward valuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Finger dexterity measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of the menstrual cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of the menstrual cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantity of the menstrual cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change over time in Inspiratory muscle strength - maximum inspiratory pressure (MIP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change over time in Expiratory muscle strength - maximum expiratory pressure (MEP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change over time in Peak Cough Flow (PCF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Homeostatic Model Assessment of Insulin Resistance (HOMA IR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Homeostasis model assessment of β-cell function (HOMA-β)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pharmacokinetic parameters of DBPR108
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful outcome in Membership of the Royal College of Surgeons examination
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Successful Annual Review of Competence Progression Outcome
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: National Training Number Appointment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to acalabrutinib treatment discontinuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients contributing data
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Data completeness of each variable
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Labile blood products measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: intra-operative total blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Average pain intensity change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early detection of patients at risk of CA-AKI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Feasibility of nutrition and exercise program
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Common Toxicity Criteria for Adverse Events (CTCAE 5.0)
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical Benefit Rate (CBR) at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from poor clinical status at 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute change in overall KCCQ summary score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total glucagon response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Rate of Deep Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Recruitment Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of patients starting Concomitant Phase postoperatively
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Overall incidence of treatment related grade ≥3 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in BOP - Bleeding On Probing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in GBI - Gingival Bleeding Index (percentage)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Radiographic bone loss (percentage)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HEAD-US score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: individual visual analog pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: presence of moderate-to-severe pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VO2 max during cardiopulmonary exercise testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test duration of cardiopulmonary exercise test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaction time of cognitive performance testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of change in the macular area of photoreceptor loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: Rate of shivering
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in peri-procedural myocardial infarction (Type 4a)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change from baseline in pain on the 10 point visual analogue scale (VAS) at week 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline in oxygen concentration in the massater muscle at week 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change from baseline in bite force values at week 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Boston Carpal Tunnel Questionnaire (BCTQ)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Electrodiagnostic evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in volume difference between extremities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of parental stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PrEP adherence single measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PrEP adherence urine sample
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of SMART IPL system for cutaneous lesions treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Safety of the suggested treatment presets
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical Global Impression Improvement scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline in Walk behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morphologic complete response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Past 30-day point prevalence abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nasal T cell responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Systemic T cell responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Systemic and nasal antibody responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Test site region reaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes in Motor Competence - process measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Motor Competence - product measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Health-related fitness - Cardiorespiratory endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in Health-related fitness - Muscular Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Health-related fitness - Body Composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Device and/or procedure-related serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline in percent correct on Knowledge of Advanced Dementia Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from Baseline in percent correct on Knowledge of Goals of Care Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change and Retention of Change in Advanced Care Planning (ACP) Engagement Survey
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Number of Participants Who Failed to Achieve Pain Freedom Within 2 Hours Post Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Reported Migraine Pain Freedom Within 2 Hours Post Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Classified Based on Satisfaction With Current Acute Treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Physical Intimate Partner Violence
Endpoint domain: Adverse events/effects
Primary endpoint: Sexual Intimate Partner Violence
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with successful drug selection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: evaluation of screw resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who discontinued BZDs at 4-month follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants who discontinued BZDs at 6-month follow-up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Protein consumption at lunch test meal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of screw or K wire placement in scaphoid bones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Accuracy of screw or K wire placement in other bones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Time of physical non-sedentary activity per week
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: distribution of cutaneous block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Back disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Participants that Agree the COPD Pathway is Feasible
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Visual Analog Scale (VAS)-Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed 25-Foot Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Daily Insulin Resistance (TDIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in the Generalized Anxiety Disorder-7 (GAD-7)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinically relevant changes in electrocardiogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence and titer anti-drug antibodies (ADA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Image quality rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of treatment-related adverse events (AE) and serious adverse events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Absolute change and percent change in LDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: NVDX3 related Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Red Blood Cells Surviving
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cost/effectiveness Ratio
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Oral Health Related Quality of Life (Child Perceptions Questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Oral Health Related Quality of Life (Psychosocial Impact of Dental Aesthetics Questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Infant Latch on Breast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient adherence to data collection method
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Sympathetic Skin Response (SSR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Valsalva left ventricular outflow tract (LVOT) gradient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in numerical rating scale (NRS 0-100 mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in intraoperative sedatives (mg) administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in opioid consumption (mg) postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal walking distance on treadmill test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial flow variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test-retest agreement of 4D flow MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Burning Mouth Syndrome symptom reports
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of New Onset Skin Cancer
Endpoint domain: Adverse events/effects
Primary endpoint: Time to Next Antidepressant Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Recurrence or Relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Changes in Sexual Functioning Questionnaire (CSFQ-14) Total Score
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Changes from baseline in pulse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from baseline in ECG QRS interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes from baseline in ECG QT interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SCSE-OAC index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative CTC-number in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of Participants with a >= 2-Grade Improvement from Baseline on the Facial Wrinkle Scale (Investigator Assessment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of Participants with a >= 2-Grade Improvement from Baseline on the Facial Wrinkle Scale (Participant Assessment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Osteoporosis-related Primary Outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sarcopenia-related Primary Outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Patient-level detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants achieving NEDA-3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 3-4-5 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of targeted tumors successfully eliminated
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of patients achieving prednisone dose of 4.0 mg or less
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in hepatic fat content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Disability progression as assessed by the Clinical Dementia Rating (CDR) scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: orthogonal maximum diameter of the aorta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Thoraco-Aortic lengths of the aorta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Infrarenal volume of the aorta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in activation of Brown Adipose Tissue (BAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: BAT glucose uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Evaluation of the Patient's Gastrointestinal Functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Quality Of Healing Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life